Vergoeding 2016-2020 voor ATC-subgroep R06AX : Overige antihistaminica voor systemisch gebruik
- Raming voor de totale Zvw-populatie
| 2016 | 2017 | 2018 | 2019 | 2020 | |
|---|---|---|---|---|---|
| R06AX13 Loratadine (Hooikoortstablet loratadine htp ®) | 312.060 | 286.070 | 279.240 | 281.080 | 288.200 |
| R06AX17 Ketotifen (Zaditen ®) | 128.080 | 132.070 | 148.170 | 148.990 | 142.710 |
| R06AX18 Acrivastine (Semprex ®) | 173.970 | 161.610 | 170.110 | 179.200 | 201.550 |
| R06AX22 Ebastine (Kestine ®) | 344.150 | 282.900 | 269.970 | 279.140 | 270.570 |
| R06AX25 Mizolastine (Mizollen ®) | 509.270 | 514.080 | 518.230 | 549.990 | 570.410 |
| R06AX26 Fexofenadine (Telfast ®) | 1.637.000 | 1.509.600 | 1.622.100 | 1.888.100 | 1.781.800 |
| R06AX27 Desloratadine (Aerius ®) | 6.388.900 | 4.646.400 | 4.742.900 | 4.987.100 | 3.851.600 |
| R06AX28 Rupatadine (Rupafin ®) | 382.330 | 356.580 | 365.630 | 511.930 | 618.300 |
| Totaal | 9.875.760 | 7.889.310 | 8.116.350 | 8.825.530 | 7.725.140 |